You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022465

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 022465 describes VOTRIENT, which is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the VOTRIENT profile page.

The generic ingredient in VOTRIENT is pazopanib hydrochloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pazopanib hydrochloride profile page.
Summary for 022465
Ingredient:pazopanib hydrochloride
Formulation / Manufacturing:see details
Generic Entry Opportunity Date for 022465
Generic Entry Date for 022465*:
Constraining patent/regulatory exclusivity:

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Suppliers and Packaging for NDA: 022465
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VOTRIENT pazopanib hydrochloride TABLET;ORAL 022465 NDA Novartis Pharmaceuticals Corporation 0078-0670 0078-0670-66 120 TABLET, FILM COATED in 1 BOTTLE (0078-0670-66)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 200MG BASE
Approval Date:Oct 19, 2009TE:RLD:Yes
Patent:  Start TrialPatent Expiration:Oct 19, 2023Product Flag?YSubstance Flag?YDelist Request?
Patent:  Start TrialPatent Expiration:Dec 19, 2021Product Flag?YSubstance Flag?YDelist Request?
Patent:  Start TrialPatent Expiration:Dec 19, 2021Product Flag?YSubstance Flag?YDelist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.